FY23 Q1 Sales Revenue Update and FY23 Forecast
Filed with ASX · · 3 pages · English
Watch Biome Australia's latest callBiome Australia (ASX:BIO) Q1 2026 Earnings Call · Replay · Oct 22, 2025Read the transcript of Biome Australia (ASX:BIO) Q1 2026 Earnings CallBiome records ~$1.56M sales revenue for September quarter (Q1 FY23) Increase of 70% versus the previous corresponding period (Q1 FY22) Sales revenue of $7M forecast for FY23 Microbiome health company Biome Australia Limited (ASX: BIO) (‘Biome’ or ‘the company’) is pleased to announce Q1 sales revenue of ~$1.56 million. This result represents 70% growth versus the previous corresponding quarter. Bi
In the deck
Earlier from Biome Australia
- FY22 Company Presentation
- FY23 Trading Update
- Biome Lift Clinical Trial Hits Recruitment Target
- Delivery of Activated Probiotics to 370 Priceline Pharmacies
- FY22 Revenue Guidance
Later from Biome Australia
- Biome records record H1 sales revenue
- Biome H1 FY23 Investor Presentation
- Biome signs corporate advisory mandate with Canary Capital
- Biome delivers record quarterly sales in Q3 FY23
- Correction to Quarterly Activities Report
Follow Biome Australia into a list and get an email when it puts out news.
Follow Biome Australia